C12N 2710/24131
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2710/24131 (Uses of virus other than therapeutic or vaccine) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 6
- Assignees
- 2
- Inventors
- 12
- Latest grant
- 30 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 2 |
| 2020 | 3 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Vaccinia virus mutants useful for cancer immunotherapy30 Jan 2024US 11,884,939 B2Memorial Sloan Kettering Cancer Center
- Vaccinia virus mutants useful for cancer immunotherapy8 Feb 2022US 11,242,509 B2Memorial Sloan Kettering Cancer Center
- Integral membrane protein display on poxvirus extracellular enveloped virions22 Dec 2020US 10,870,707 B2Vaccinex, Inc.
- Integral membrane protein display on poxvirus extracellular enveloped virions3 Mar 2020US 10,577,427 B2Vaccinex, Inc.
- Integral membrane protein display on poxvirus extracellular enveloped virions4 Feb 2020US 10,550,199 B2Vaccinex, Inc.
- Vaccinia virus mutants useful for cancer immunotherapy16 Jun 2022US 2022/0186192 A1Memorial Sloan Kettering Cancer Center
- Heat-inactivated vaccinia virus as a vaccine immune adjuvant17 Jun 2021US 2021/0177964 A1Memorial Sloan Kettering Cancer Center
- Vaccinia virus mutants useful for cancer immunotherapy29 Oct 2020US 2020/0339959 A1Memorial Sloan Kettering Cancer Center
- Integral membrane protien display on poxvirus extracellular enveloped virions9 Jul 2020US 2020/0216562 A1Vaccinex, Inc.
- Integral membrane protein display on poxvirus extracellular enveloped virions12 Sep 2019US 2019/0276556 A1Vaccinex, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.